|
Yale Cancer Center NCTN
|
5U10CA180826-05
|
$700,035
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-05
|
$542,950
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-05
|
$1,394,352
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S1
|
$218,356
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S2
|
$203,848
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S3
|
$86,197
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
5P30CA016059-37
|
$2,170,000
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-06
|
$503,410
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of Critical 1q21 Vulnerabilities in Multiple Myeloma
|
1R01CA222253-01
|
$381,997
|
COLLA, SIMONA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Validating the eCyPA/CD147 signaling complex for myeloma therapy
|
5R01CA196783-04
|
$394,823
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INST
|
|
Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma
|
5R33CA196470-03
|
$386,051
|
LIN, QIAO
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA
|
5R01CA180475-05
|
$347,390
|
LICHT, JONATHAN
|
UNIVERSITY OF FLORIDA
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-05
|
$644,932
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-05
|
$1,267,600
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
USP7 inhibitors for the treatment of multiple myeloma
|
5R01CA211681-02
|
$504,721
|
BUHRLAGE, SARA
|
DANA-FARBER CANCER INST
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
2P30CA177558-06
|
$2,152,710
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-06S1
|
$101,000
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-06S2
|
$241,905
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-06S3
|
$200,000
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-06S4
|
$213,531
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
3P30CA023074-38S1
|
$200,000
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
3P30CA023074-38S2
|
$249,999
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
3P30CA023074-38S3
|
$112,000
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
3P30CA023074-38S4
|
$300,000
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
5P30CA023074-38
|
$3,533,423
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
UM LAPs- U10 Grant
|
5U10CA180801-05
|
$763,048
|
ZALUPSKI, MARK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-05
|
$623,007
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Ubiquitin signaling for protein degradation
|
ZIA BC 011490
|
$1,003,463
|
Walters, Kylie
|
CCR (NCI)
|
|
Tumor Cell-Intrinsic/Extrinsic Mechanisms Underlying Myeloma Disease Progression
|
5R01CA196831-04
|
$363,713
|
JELINEK, DIANE
|
MAYO CLINIC ROCHESTER
|
|
Treatment of multiple myeloma using oncolytic myxoma virus
|
5R01CA194090-03
|
$341,981
|
BARTEE, ERIC
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Transient anti-BCMA CAR T-cells for Treatment of Multiple Myeloma
|
1R43CA221432-01A1
|
$299,042
|
STEWART, CHARLES
|
CARTESIAN THERAPEUTICS, INC.
|
|
Transcription and Splicing Dynamics in Single Cells
|
ZIA BC 011383
|
$964,491
|
Larson, Daniel
|
CCR (NCI)
|
|
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
|
5R01CA207237-03
|
$395,166
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
3P30CA196521-04S1
|
$249,999
|
PARSONS, RAMON
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
3P30CA196521-04S2
|
$224,981
|
PARSONS, RAMON
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
5P30CA196521-04
|
$2,373,000
|
PARSONS, RAMON
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The thrombospondin1-TGF-beta axis in multiple myeloma
|
5R01CA175012-05
|
$598,327
|
MURPHY-ULLRICH, JOANNE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
|
5R01CA195732-03
|
$348,844
|
LICHT, JONATHAN
|
UNIVERSITY OF FLORIDA
|
|
The Role of MMP13 in Multiple Myeloma Bone Disease
|
5R01CA175313-05
|
$331,098
|
LENTZSCH, SUZANNE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of intestinal microbiota in graft-versus-host disease
|
1R01CA228308-01
|
$525,957
|
VAN DEN BRINK, MARCEL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The Role of Cereblon Pathways in Myeloma
|
5R01CA183968-05
|
$446,267
|
STEWART, ALEXANDER
|
MAYO CLINIC ARIZONA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|